Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
biotech
boston blog main
5
×
life sciences
national blog main
rna
5
×
national top stories
san francisco blog main
san francisco top stories
boston top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
texas blog main
texas top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
clinical trials
deals
detroit blog main
detroit top stories
editas medicine
fda
gene therapy
hemophilia
indiana blog main
indiana top stories
ipo
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
startups
venture capital
wisconsin blog main
wisconsin top stories
abbvie
What
medicine
bio
gene
help
ipo
long
roundup
scientists
acquisitions
alike
announced
antonio
arena’s
badylak
beam
bounty
cas
ceo
cig
collabs
comeback
companies
corner
covid
crispr
crude
cutting
daniel
deal
deals
delivered
despite
dreamed
edge
editas
editing
editor
effects
encoded
expressing
Language
unset
Current search:
rna
×
photo
×
" boston blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
San Antonio to Honor Regenerative Medicine Pioneer Stephen Badylak
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
6 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M